Clinical Trial Update: Phase 1 Study of GEN0101 in Patients With Recurrence of CRPC [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for GEN0101 in patients with recurrent castration-resistant prostate cancer; the trial status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Castration-resistant Prostate Cancer

Drugs mentioned

• GEN0101

Snippet

Sponsor: Norio Nonomura | Conditions: Castration Resistant Prostate Cancer | Phase 1 | Status: UNKNOWN